Sio Gene Therapies SIOX
$ 0.42
2.09%
Quarterly report 2022-Q4
added 02-14-2023
Country |
Britain |
IPO year |
- |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
- |
Employees in the company |
- |
Shares |
52.2 M |
Market Cap[1] |
$ 30.3 M |
EBITDA (LTM) |
$ -56.2 M |
P/E (LTM) |
-0.68 |
P/S (LTM) |
- |
EPS (LTM) |
-0.6 |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.